Ruzurgi®

Date: 09/13/2021

Product Description

Ruzurgi® (amifampridine) 10 mg tablets

Recall Reason Description

Exceeds Specification for Total Yeast and Mold Counts

Company Name

Jacobus Pharmaceutical Company Inc.

US FDA Link: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/jacobus-pharmaceutical-company-inc-issues-voluntary-worldwide-recall-ruzurgir-amifampridine-10-mg